Global Hypodemic Needle Market - Forecasts from 2019 to 2024
The global hypodermic needle market is evaluated at US$ 2,489.851 million for the year 2018. A hypodermic needle is a hollow needle commonly used with a syringe to inject substances into the body or extract fluids from it. Hypodermic needle provides rapid delivery of the liquids and is used to deliver drugs that cannot be ingested or absorbed orally. These needles are therefore used for different applications such as drug delivery, vaccination, and blood specimen collection. The market is expected to show significant growth during the forecast period. The growth may be attributed to the rising prevalence of chronic diseases such as diabetes and cancer across the globe. Technological advancements in hypodermic needle-based drug delivery will also boost the market for hypodermic needle. However, availability of the alternative modes of drug delivery might restrict the growth of the market. The growth of the market may also be hampered by the lack of awareness regarding the use of hypodermic needles in the emerging economies during the given time frame.
The “Global Hypodermic Needle Market – Forecasts from 2019 to 2024” is an exhaustive study which aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, application, end-user, and geography.
The global hypodermic needle market has been segmented based on type, application, end-user, and geography. By type, the market has been segmented into safety hypodermic needle, non-safety hypodermic needle. By application the market is segmented into drug delivery, vaccination, body fluid collection. By the end-user, the market is segmented into hospitals and clinics, ambulatory care centers, diagnostic centers and others.
Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and Asia Pacific regions. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major players in the global hypodermic needle market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the global hypodermic needle market.
Segmentation
Global Hypodermic Needle market has been segmented as follows:
By Type
The “Global Hypodermic Needle Market – Forecasts from 2019 to 2024” is an exhaustive study which aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, application, end-user, and geography.
The global hypodermic needle market has been segmented based on type, application, end-user, and geography. By type, the market has been segmented into safety hypodermic needle, non-safety hypodermic needle. By application the market is segmented into drug delivery, vaccination, body fluid collection. By the end-user, the market is segmented into hospitals and clinics, ambulatory care centers, diagnostic centers and others.
Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and Asia Pacific regions. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major players in the global hypodermic needle market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the global hypodermic needle market.
Segmentation
Global Hypodermic Needle market has been segmented as follows:
By Type
- Safety Hypodermic Needle
- Non-Safety Hypodermic Needle
- Drug Delivery
- Vaccination
- Body Fluid Collection
- Hospitals and Clinics
- Ambulatory Care Centres
- Diagnostic Centres
- Others
- North America
- United States
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Middle East and Africa
- Saudi Arabia
- Israel
- Others
- Asia Pacific
- China
- Japan
- India
- South Korea
- Others
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. GLOBAL HYPODERMIC NEEDLE MARKET BY TYPE
5.1. Safety Hypodermic Needle
5.2. Non-Safety Hypodermic Needle
6. GLOBAL HYPODERMIC NEEDLE MARKET BY APPLICATION
6.1. Drug Delivery
6.2. Vaccination
6.3. Body Fluid Collection
7. GLOBAL HYPODERMIC NEEDLE MARKET BY END USER
7.1. Hospitals and Clinics
7.2. Ambulatory Care Centres
7.3. Diagnostic Centres
7.4. Others
8. GLOBAL HYPODERMIC NEEDLE MARKET BY GEOGRAPHY
8.1. North America
8.1.1. United States
8.1.2. Canada
8.1.3. Mexico
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. United Kingdom
8.3.2. Germany
8.3.3. France
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. Israel
8.4.3. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Competitive Benchmarking and Analysis
9.2. Recent Investments and Deals
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. Connecticut Hypodermics, Inc.
10.2. Nipro Medical
10.3. Becton, Dickinson and Company
10.4. Victor - G. & Company
10.5. Vita Needle Company
10.6. B. Braun Melsungen AG
10.7. Cardinal Health
10.8. Terumo Medical NV
10.9. Smiths Group plc
LIST OF FIGURES
LIST OF TABLES
